ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 63 filers reported holding ORCHARD THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $851,562 | -26.0% | 2,295,315 | -0.3% | 0.00% | – |
Q3 2022 | $1,151,000 | +5131.8% | 2,301,742 | +6119.4% | 0.00% | – |
Q2 2022 | $22,000 | -81.0% | 37,009 | -77.2% | 0.00% | – |
Q1 2022 | $116,000 | -59.6% | 162,207 | -25.5% | 0.00% | – |
Q4 2021 | $287,000 | -55.9% | 217,839 | -23.1% | 0.00% | – |
Q3 2021 | $651,000 | -50.6% | 283,165 | -5.8% | 0.00% | – |
Q2 2021 | $1,319,000 | -53.3% | 300,609 | -22.8% | 0.00% | -100.0% |
Q1 2021 | $2,827,000 | +731.5% | 389,482 | +395.3% | 0.00% | – |
Q4 2020 | $340,000 | +85.8% | 78,630 | +76.4% | 0.00% | – |
Q3 2020 | $183,000 | -97.7% | 44,579 | -96.7% | 0.00% | -100.0% |
Q2 2020 | $8,118,000 | +24.6% | 1,353,114 | +56.4% | 0.00% | 0.0% |
Q1 2020 | $6,514,000 | -6.4% | 865,045 | +71.0% | 0.00% | 0.0% |
Q4 2019 | $6,956,000 | -9.3% | 505,877 | -21.7% | 0.00% | -25.0% |
Q3 2019 | $7,673,000 | – | 645,860 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 2,931,185 | $12,047,000 | 4.29% |
RA Capital Management | 12,315,213 | $50,616,000 | 0.93% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $28,562,000 | 0.70% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 620,233 | $2,549,000 | 0.35% |
Casdin Capital, LLC | 1,870,000 | $7,686,000 | 0.34% |
Vivo Capital, LLC | 1,325,736 | $5,449,000 | 0.32% |
Bleichroeder LP | 250,000 | $1,028,000 | 0.18% |
Virtus ETF Advisers LLC | 40,292 | $166,000 | 0.09% |
Forefront Analytics, LLC | 30,369 | $123,000 | 0.06% |
PLATINUM INVESTMENT MANAGEMENT LTD | 411,977 | $1,693,000 | 0.04% |